A detailed history of Compass Capital Management, Inc transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Compass Capital Management, Inc holds 102,137 shares of TMO stock, worth $54 Million. This represents 4.21% of its overall portfolio holdings.

Number of Shares
102,137
Previous 102,839 0.68%
Holding current value
$54 Million
Previous $56.9 Million 11.09%
% of portfolio
4.21%
Previous 3.84%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$531.86 - $624.21 $373,365 - $438,195
-702 Reduced 0.68%
102,137 $63.2 Million
Q2 2024

Jul 25, 2024

SELL
$541.52 - $599.02 $509,570 - $563,677
-941 Reduced 0.91%
102,839 $56.9 Million
Q1 2024

Apr 29, 2024

BUY
$528.82 - $599.43 $513,484 - $582,046
971 Added 0.94%
103,780 $60.3 Million
Q4 2023

Feb 05, 2024

BUY
$431.41 - $532.94 $3.14 Million - $3.88 Million
7,288 Added 7.63%
102,809 $54.6 Million
Q3 2023

Oct 27, 2023

SELL
$498.29 - $574.41 $1.98 Million - $2.29 Million
-3,982 Reduced 4.0%
95,521 $48.3 Million
Q2 2023

Jul 31, 2023

BUY
$508.46 - $591.13 $1.89 Million - $2.2 Million
3,725 Added 3.89%
99,503 $51.9 Million
Q1 2023

May 01, 2023

SELL
$535.0 - $604.82 $532,325 - $601,795
-995 Reduced 1.03%
95,778 $55.2 Million
Q4 2022

Jan 27, 2023

SELL
$484.71 - $571.37 $681,986 - $803,917
-1,407 Reduced 1.43%
96,773 $53.3 Million
Q3 2022

Oct 26, 2022

SELL
$507.19 - $604.49 $1.05 Million - $1.25 Million
-2,074 Reduced 2.07%
98,180 $49.8 Million
Q2 2022

Jul 27, 2022

BUY
$500.9 - $612.21 $92,165 - $112,646
184 Added 0.18%
100,254 $54.5 Million
Q1 2022

May 06, 2022

BUY
$524.0 - $644.92 $580,068 - $713,926
1,107 Added 1.12%
100,070 $59.1 Million
Q4 2021

Jan 31, 2022

SELL
$569.0 - $667.24 $2.4 Million - $2.82 Million
-4,219 Reduced 4.09%
98,963 $66 Million
Q3 2021

Nov 05, 2021

SELL
$509.53 - $609.78 $2.96 Million - $3.55 Million
-5,814 Reduced 5.33%
103,182 $59 Million
Q2 2021

Aug 09, 2021

BUY
$441.0 - $508.24 $3.6 Million - $4.15 Million
8,164 Added 8.1%
108,996 $55 Million
Q1 2021

Apr 29, 2021

BUY
$439.85 - $518.83 $1.85 Million - $2.18 Million
4,197 Added 4.34%
100,832 $46 Million
Q4 2020

Feb 05, 2021

SELL
$435.06 - $527.66 $1.87 Million - $2.27 Million
-4,296 Reduced 4.26%
96,635 $45 Million
Q3 2020

Nov 12, 2020

SELL
$359.77 - $441.52 $2.53 Million - $3.1 Million
-7,024 Reduced 6.51%
100,931 $44.6 Million
Q2 2020

Aug 06, 2020

SELL
$275.2 - $362.34 $2.12 Million - $2.79 Million
-7,702 Reduced 6.66%
107,955 $39.1 Million
Q1 2020

Apr 24, 2020

SELL
$255.3 - $340.05 $1.98 Million - $2.63 Million
-7,744 Reduced 6.28%
115,657 $32.8 Million
Q4 2019

Jan 30, 2020

SELL
$271.93 - $328.04 $240,929 - $290,643
-886 Reduced 0.71%
123,401 $40.1 Million
Q3 2019

Oct 22, 2019

BUY
$268.46 - $305.43 $41,611 - $47,341
155 Added 0.12%
124,287 $36.2 Million
Q2 2019

Jul 31, 2019

SELL
$257.51 - $295.55 $461,972 - $530,216
-1,794 Reduced 1.42%
124,132 $36.5 Million
Q1 2019

May 06, 2019

SELL
$212.17 - $273.72 $1.54 Million - $1.99 Million
-7,261 Reduced 5.45%
125,926 $34.5 Million
Q4 2018

Jan 28, 2019

BUY
$208.47 - $251.98 $63,791 - $77,105
306 Added 0.23%
133,187 $29.8 Million
Q3 2018

Oct 31, 2018

SELL
$205.57 - $244.32 $394,694 - $469,094
-1,920 Reduced 1.42%
132,881 $32.4 Million
Q2 2018

Jul 20, 2018

SELL
$203.14 - $219.53 $819,873 - $886,023
-4,036 Reduced 2.91%
134,801 $27.9 Million
Q1 2018

Apr 27, 2018

SELL
$192.98 - $224.11 $563,501 - $654,401
-2,920 Reduced 2.06%
138,837 $28.7 Million
Q4 2017

Jan 30, 2018

BUY
$182.03 - $200.37 $594,145 - $654,007
3,264 Added 2.36%
141,757 $26.9 Million
Q3 2017

Nov 01, 2017

BUY
$171.74 - $194.04 $23.8 Million - $26.9 Million
138,493
138,493 $26.2 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $207B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Compass Capital Management, Inc Portfolio

Follow Compass Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Compass Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Compass Capital Management, Inc with notifications on news.